期刊文献+

氨基末端脑钠尿肽激素原对小儿心功能的评估 被引量:2

Clinical value of amino-terminal pro brain natriuretic peptide in pediatric cardiology
下载PDF
导出
摘要 氨基末端脑钠尿肽激素原现已被证实为成人充血性心力衰竭诊断、疗效监测、预后评估等的有效标志。它的血浆浓度同左室射血分数呈负相关,与临床心衰程度评分呈正相关。该文主要综述小儿氨基末端脑钠尿肽激素原的正常值范围及其对小儿心力衰竭或心功能不全的诊断、治疗监测等方面的最新进展。 Amino-terminal pro brain natriuretic peptide(NT-proBNP), has been shown to be an effective indicator for diagnosis, therapeutic effect monitoring and prognosis assessment in adult congestive heart failure. NT-proBNP serum levels shown a negative correlation with the ejection fraction and a positive correlation with the clinical heart failure severity score. The purpose of this article is to review the current progress in study on the usefulness of NT-proBNP for diagnosis, monitoring and ventricular dysfunction. normal range of NT-proBNP in neonatal period and childhood, the predicting prognosis of children with congestive heart failure or left
作者 陈铃 朱红枫
出处 《中国妇幼健康研究》 2006年第3期202-205,共4页 Chinese Journal of Woman and Child Health Research
关键词 氨基末端脑钠尿肽激素原 心力衰竭 新生儿 儿童 amino-terminal pro brain natriuretic peptide(NT-proBNP) heart failure neonate children
  • 相关文献

参考文献24

  • 1Yeo K T,Dumont K E,Brough T.Elecsys NT-ProBNP and BNP assays:are there analytically and clinically relevant differences[J]? J Card Fail,2005,11(5 Suppl):S84-S88.
  • 2Mir T S,Laux R,Hellwege H H,et al.Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates:marked and rapid increase after birth[J].Pediatrics,2003,112:896-899.
  • 3Mir T S,Marohn S,Laer S,et al.P1asm concentrations of N-terminal pro-brain natriurfic peptide in control children from the neonatal to adolescent period and in children with congestive heartfailure[J].Pediatrics,2002,110:E76
  • 4Nir A,Nasser N.Clinical value of NT-ProBNP and BNP in pediatric cardiology[J].J Card Fail,2005,11(5 Suppl):S76-S80
  • 5Hobbs F D,Davis R C,Roalfe A K,et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure:cohort study in representative and high risk community populations[J].BMJ,2002,324(7352):1498.
  • 6Mueller T,Gegenhuber A,Poelz W,et al.Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay:implications for the prediction of symptomatic and asymptomatic structural heart disease[J].Clin Chem,2003,49(6 Pt 1):976-979.
  • 7Schwachtgen L,Herrmann M,Georg T,et al.Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children[J].Z Kardiol,2005,94(6):399-404.
  • 8Rauh M,Koch A.Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children[J].Clin Chem,2003,49(9):1563-1564.
  • 9Nir A,Bar O B,Perles Z,et al.N-terminal pro-B-type natriuretic peptide:reference plasma levels from birth to adolescence:Elevated levels at birth and in infants and children with heart diseases[J].Acta Paediatr,2004,93(5):603-607.
  • 10Soldin S J,Soldin O P,Boyajian A J,et al.Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals[J].Clin Chim Acta,2006,366(1-2):304-308.

同被引文献28

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部